Led by Dr Allan Dietz at the Mayo Clinic, this clinical trial will investigate the safety and potential therapeutic effects of mesenchymal stem cells derived from the patients own adipose tissue (body fat).
Eligible participants include those with sub-acute or chronic traumatic injuries at any level, with AIS grade A or B.
40 volunteers will be recruited and split into two groups. The first will receive the cells at the start of the study. The second group will be observed over six months while attending physical and occupational therapy. After six months, patients will receive a single dose of the stem cells.
The trial in recruiting now.